The Asia-Pacific Anti-snoring devices and snoring surgery Market is accounted to reach USD USD 3,756.55 million by 2024 from USD 1,654.64 million in 2016, at a CAGR of 10.9% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are the rise in the geriatric as well as obese population, more of technological advancement, growing awareness regarding ill effects of snoring and related advantages, increase in the consumption of cigarettes and alcohol are furthermore boosting the growth of the global anti-snoring devices and snoring surgery market. On the other hand, unfavourable reimbursement policies, and high cost of surgeries and custom-made oral devices may hinder the growth of the market. The anti-snoring devices and snoring surgery market in the Asia-Pacific region is leading in Japan.
The key market players for Asia-Pacific Anti-snoring devices and snoring surgery Market are listed below;
GE Healthcare,
Medtronic a
Koninklijke
Philips N.V.
The market is further segmented into;
hospitals,
home healthcare,
sleep clinics,
community healthcare
others
The Asia-Pacific anti-snoring devices and snoring surgery market is segmented on the basis of product type, end user and distribution channel. Based on type, the Asia-Pacific anti-snoring devices and snoring surgery market is segmented on the basis of product type into six oral appliances/mouthpieces, nasal devices, EPAP (Expiratory Positive Airway Pressure) therapy devices, continuous positive airway pressure (CPAP) devices, position control devices, chin straps. In 2017, oral appliances/mouthpieces segment is expected to dominate the Asia-Pacific anti-snoring devices and snoring surgery market with 42.8% market share and is expected to reach USD 1599.83 million by 2024, with a CAGR of 10.9% in the forecast period 2017 to 2024. However, nasal devices segment is expected to grow at the highest CAGR of 12.3% in the forecast period, and is expected to reach USD 1198.05 million in 2024 from USD 480.52 million in 2016.
The Asia-Pacific anti-snoring devices and snoring surgery market is segmented based on type into six notable segments; Uvulopalatopharyngoplasty (UPPP), Laser-Assisted Uvulopalatoplasty (LAUP), Radiofrequency Ablation (somnoplasty), Pillar Procedure, Palatal Stiffening Procedures, Injection Snoreplasty/Sclerotherapy and Others. In 2017, Uvulopalatopharyngoplasty (UPPP) segment is expected to dominate the Asia-Pacific anti-snoring devices and snoring surgery devices and snoring surgery market with 34.0% market share and is expected to reach USD 1,226.02 million by 2024, with a CAGR of 11.0% in the forecast period 2017 to 2024. However, Radiofrequency Ablation (somnoplasty) segment is expected to grow with the highest CAGR of 12.4% in the forecast period, and is expected to reach USD 747.84 million in 2024 from USD 296.16 million in 2016.
On the basis of end user, the Asia-Pacific anti-snoring devices and snoring surgery market is segmented into five notable segments; hospitals, home healthcare, sleep clinics, community healthcare and others. In 2017, hospitals segment is expected to dominate the Asia-Pacific anti-snoring devices and snoring surgery market with 59.0% market share and is expected to reach USD 2116.72 million by 2024, with a CAGR of 10.2% in the forecast period 2017 to 2024. However, home healthcare segment is expected to grow at the highest CAGR of 12.4% in the forecast period, and is expected to reach USD 1042.31 million in 2024 from USD 412.33 million in 2016.
On the basis of distribution channel, the Asia-Pacific anti-snoring devices and snoring surgery market is classified into retail and direct sales. In 2017, retail segment is expected to dominate the Asia-Pacific anti-snoring devices and snoring surgery market with 77.9% market share and is expected to reach USD 3004.87 million by 2024, with the highest CAGR of 11.4% in the forecast period 2017 to 2024.
Based on geography, the Asia-Pacific Anti-snoring devices and snoring surgery market is segmented into geographical regions, such as,
Germany,
China,
Japan,
India,
South Korea,
Australia,
Thailand,
Malaysia,
Singapore,
Indonesia,
Philippines
Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Anti-snoring devices and snoring surgery Market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
